Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» JNJ
JNJ
EU To Fine J&J And Novartis Over A Pay-To-Delay Deal
Pharmalot
Mon, 11/25/13 - 09:01 am
Europe
JNJ
Novartis
pay-for-delay
generics
Sandoz
Fentanyl
pain patches
J&J, Medivir Win U.S. FDA Approval for Hepatitis C Pill
Bloomberg
Sat, 11/23/13 - 12:49 pm
JNJ
Medvir
hepatitis C
hepatitis
Olysio
simeprevir
J&J Said to Narrow Bidder List to 3 for Diagnostics Business
Bloomberg
Fri, 11/22/13 - 11:01 am
JNJ
M&A
diagnostics
Ortho Clinical Diagnostics
Two Dozen Drugmakers Pay $88M To Louisiana Over Inflated Prices
Pharmalot
Thu, 11/21/13 - 10:11 am
Louisiana
drug pricing
Novartis
Sanofi
JNJ
Par Pharmaceutical
Ranbaxy
Abbott Laboratories
Will Recent News Hurt Johnson & Johnson?
Wall St Cheat Sheet
Thu, 11/21/13 - 08:32 am
JNJ
Vertex Gains on Sale of Drug Rights to Johnson & Johnson Unit
Barron's
Wed, 11/20/13 - 04:37 pm
Vertex Pharmaceuticals
JNJ
Incivo
Janssen
hepatitis C
J&J shares are helped by findings on stroke-prevention medication
Marketwatch
Wed, 11/20/13 - 08:41 am
JNJ
Xarelto
Janssen
Celgene Vs. Rivals In Psoriatic Arthritis Drug Race
Seeking Alpha
Wed, 11/20/13 - 08:29 am
psoriatic arthritis
Celgene
AbbVie
Amgen
JNJ
Merck
Humira
apremilast
Enbrel
Stelara
Simponi
Remicade
WSJ: J&J’s hip-implant settlement will be lower than expected
Marketwatch
Tue, 11/19/13 - 12:42 pm
JNJ
hip implants
recalls
Alzheimer's Disease Could Become the Next Frontier in Pharmaceutical Research
Motley Fool
Tue, 11/19/13 - 07:40 am
Alzheimer's disease
R&D
JNJ
Eli Lilly
Pfizer
Elan
General Electric
Vizamyl
Amyvid
bapineuzumab
solanezumab
J&J’s Janssen Loses $11 Million Jury Verdict Over Topamax
Bloomberg
Tue, 11/19/13 - 07:38 am
Janssen
JNJ
Topamax
birth defects
Celgene's Revlimid Faces a Tough Sell
Motley Fool
Tue, 11/19/13 - 07:25 am
Celgene
Revlimid
JNJ
Multiple Myeloma
Johnson & Johnson’s Imbruvica Will Be a Costly Treatment
Wall St Cheat Sheet
Mon, 11/18/13 - 04:36 pm
JNJ
Imbruvica
mantle cell lymphoma
Pharmacyclics
Johnson & Johnson Vs. Medivation In Prostate Cancer Race
Seeking Alpha
Mon, 11/18/13 - 08:19 am
JNJ
Medivation
prostate cancer
Xtandi
Astellas
Zytiga
J&J Said to Announce $4 Billion Hip-Implant Pact Nov. 19
Bloomberg
Sat, 11/16/13 - 01:30 pm
JNJ
hip implants
devices
settlements
lawsuits
This Week in Biotech
Motley Fool
Sat, 11/16/13 - 01:23 pm
Vanda
Cadence Pharmaceuticals
Immunogen
Novartis
Pharmacyclics
JNJ
Epizyme
Sarepta Therapeutics
GSK
The Anti-Kickback Statute And The Affordable Care Act: A Law Enforcement Tool Suddenly Goes Missing
Forbes
Wed, 11/13/13 - 12:51 pm
Affordable Care Act
kickbacks
anti-kickback statute
JNJ
Alzheimer’s Clues Sought Studying Link to Down Syndrome
Bloomberg
Wed, 11/13/13 - 08:44 am
Downs Syndrome
JNJ
Alzheimer's disease
J&J Said to Reach $4 Billion Deal to Settle Hip Lawsuits
Bloomberg
Tue, 11/12/13 - 04:55 pm
JNJ
hip implants
devices
recalls
DePuy
J&J's Velcade gets stiff-armed at NICE as first-line myeloma treatment
Fierce Pharma
Tue, 11/12/13 - 04:37 pm
JNJ
Velcade
Multiple Myeloma
Pages
« first
‹ previous
…
109
110
111
112
113
114
115
116
117
…
next ›
last »